Cargando…

Blockchain technology in the pharmaceutical industry: a systematic review

Blockchain technology is accelerating digital transformation across multiple industries, including the pharmaceutical industry. The pharmaceutical industry suffers from a lack of transparency, difficulty tracking products, lack of trust, and the shipment of expired products. Blockchain technology ha...

Descripción completa

Detalles Bibliográficos
Autores principales: Zakari, Nazik, Al-Razgan, Muna, Alsaadi, Amani, Alshareef, Haya, Al saigh, Heba, Alashaikh, Lamia, Alharbi, Mala, Alomar, Rana, Alotaibi, Seham
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PeerJ Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9137953/
https://www.ncbi.nlm.nih.gov/pubmed/35634106
http://dx.doi.org/10.7717/peerj-cs.840
_version_ 1784714506702684160
author Zakari, Nazik
Al-Razgan, Muna
Alsaadi, Amani
Alshareef, Haya
Al saigh, Heba
Alashaikh, Lamia
Alharbi, Mala
Alomar, Rana
Alotaibi, Seham
author_facet Zakari, Nazik
Al-Razgan, Muna
Alsaadi, Amani
Alshareef, Haya
Al saigh, Heba
Alashaikh, Lamia
Alharbi, Mala
Alomar, Rana
Alotaibi, Seham
author_sort Zakari, Nazik
collection PubMed
description Blockchain technology is accelerating digital transformation across multiple industries, including the pharmaceutical industry. The pharmaceutical industry suffers from a lack of transparency, difficulty tracking products, lack of trust, and the shipment of expired products. Blockchain technology has been applied to solve several of these problems. In this paper, we present a systematic review of the literature focusing on the adoption of blockchain technology in the pharmaceutical industry. We collected, analyzed, qualified, and discussed studies retrieved from seven databases. The initial search yielded 2,185 papers, which were screened, discussed, voted on, critically appraised, and collected by a snowball workflow that finally yielded 38 papers. The blockchain application areas covered in the papers were classified as counterfeit drug prevention, drug distribution, tracking and tracing, and safety and security. The most frequent category was counterfeit drug prevention, which is consistent with the primary objective of the pharmaceutical industry. The newer topics discussed in this study were data governance, data quality, pharmaceutical turnover, and prescription drug monitoring. We discuss issues surrounding each of these topics and research studies, along with their limitations and solutions. We also examine the challenges and future research directions of applying blockchain technology in the pharmaceutical industry.
format Online
Article
Text
id pubmed-9137953
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher PeerJ Inc.
record_format MEDLINE/PubMed
spelling pubmed-91379532022-05-28 Blockchain technology in the pharmaceutical industry: a systematic review Zakari, Nazik Al-Razgan, Muna Alsaadi, Amani Alshareef, Haya Al saigh, Heba Alashaikh, Lamia Alharbi, Mala Alomar, Rana Alotaibi, Seham PeerJ Comput Sci Agents and Multi-Agent Systems Blockchain technology is accelerating digital transformation across multiple industries, including the pharmaceutical industry. The pharmaceutical industry suffers from a lack of transparency, difficulty tracking products, lack of trust, and the shipment of expired products. Blockchain technology has been applied to solve several of these problems. In this paper, we present a systematic review of the literature focusing on the adoption of blockchain technology in the pharmaceutical industry. We collected, analyzed, qualified, and discussed studies retrieved from seven databases. The initial search yielded 2,185 papers, which were screened, discussed, voted on, critically appraised, and collected by a snowball workflow that finally yielded 38 papers. The blockchain application areas covered in the papers were classified as counterfeit drug prevention, drug distribution, tracking and tracing, and safety and security. The most frequent category was counterfeit drug prevention, which is consistent with the primary objective of the pharmaceutical industry. The newer topics discussed in this study were data governance, data quality, pharmaceutical turnover, and prescription drug monitoring. We discuss issues surrounding each of these topics and research studies, along with their limitations and solutions. We also examine the challenges and future research directions of applying blockchain technology in the pharmaceutical industry. PeerJ Inc. 2022-03-11 /pmc/articles/PMC9137953/ /pubmed/35634106 http://dx.doi.org/10.7717/peerj-cs.840 Text en ©2022 Zakari et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ Computer Science) and either DOI or URL of the article must be cited.
spellingShingle Agents and Multi-Agent Systems
Zakari, Nazik
Al-Razgan, Muna
Alsaadi, Amani
Alshareef, Haya
Al saigh, Heba
Alashaikh, Lamia
Alharbi, Mala
Alomar, Rana
Alotaibi, Seham
Blockchain technology in the pharmaceutical industry: a systematic review
title Blockchain technology in the pharmaceutical industry: a systematic review
title_full Blockchain technology in the pharmaceutical industry: a systematic review
title_fullStr Blockchain technology in the pharmaceutical industry: a systematic review
title_full_unstemmed Blockchain technology in the pharmaceutical industry: a systematic review
title_short Blockchain technology in the pharmaceutical industry: a systematic review
title_sort blockchain technology in the pharmaceutical industry: a systematic review
topic Agents and Multi-Agent Systems
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9137953/
https://www.ncbi.nlm.nih.gov/pubmed/35634106
http://dx.doi.org/10.7717/peerj-cs.840
work_keys_str_mv AT zakarinazik blockchaintechnologyinthepharmaceuticalindustryasystematicreview
AT alrazganmuna blockchaintechnologyinthepharmaceuticalindustryasystematicreview
AT alsaadiamani blockchaintechnologyinthepharmaceuticalindustryasystematicreview
AT alshareefhaya blockchaintechnologyinthepharmaceuticalindustryasystematicreview
AT alsaighheba blockchaintechnologyinthepharmaceuticalindustryasystematicreview
AT alashaikhlamia blockchaintechnologyinthepharmaceuticalindustryasystematicreview
AT alharbimala blockchaintechnologyinthepharmaceuticalindustryasystematicreview
AT alomarrana blockchaintechnologyinthepharmaceuticalindustryasystematicreview
AT alotaibiseham blockchaintechnologyinthepharmaceuticalindustryasystematicreview